Carcinoembryonic Antigen (CEA)

Carcinoembryonic antigen (CEA) is a protein normally present at very low levels in the blood of healthy adults. A CEA test measures how much is circulating and is most often used to follow a condition that is already known.

bloodng/mL · µg/LAlso known as CEA, Antígeno carcinoembrionario, Carzinoembryonales Antigen

Reviewed by LifeFrom’s medical AI

The distinctions
  1. 01
    A monitoring marker, not a cancer screen

    CEA was built to follow a cancer that is already diagnosed, watching whether treatment works or whether it returns. It fails as a screen in both directions: smoking and benign conditions push it up when there is no cancer, while many colorectal cancers never raise it, so a high result is usually not cancer and a normal result rules nothing out.

  2. 02
    The trend beats the number

    One CEA value says little. What a care team reads is the direction across repeated tests over months, which is why the marker earns its place after a diagnosis and not before.

If your CEA result came back high, start with this. A high CEA is usually not cancer. CEA, short for carcinoembryonic antigen, is a protein that cancer cells and healthy cells both make, and it was designed to track a cancer that has already been diagnosed, not to find one in a healthy person. Smoking alone raises it, and so do several benign conditions.

What is a CEA blood test?

CEA is a glycoprotein (a protein with sugar chains attached) that appears in the digestive tissue of a developing fetus and falls to low levels after birth. 4 In adults, small amounts still circulate, and both tumors and healthy tissue can raise it. The National Cancer Institute defines a tumor marker as a substance produced by cancer cells or by other cells of the body in response to cancer or certain benign conditions, 1 which is why CEA turns up in so many situations that have nothing to do with a tumor.

What is CEA used for?

CEA earns its keep after a cancer diagnosis, mainly colorectal cancer. A doctor measures it before treatment to set a baseline, then repeats it to see whether the number falls (a sign treatment is working) and later whether it climbs (a possible sign the cancer has returned).

Mayo Clinic Laboratories notes that after a colorectal tumor is removed, CEA should return to normal within about 6 weeks; a value that stays up, or rises months later, is the signal a care team watches. 4 The American Society of Clinical Oncology endorses checking CEA every 3 to 6 months for up to 5 years in people treated for stage II or III colorectal cancer, alongside scans and colonoscopy, not on its own. 2 Serial (repeat) testing catches a recurrence about 80% of the time and can give roughly a 5-month head start over symptoms, which is where its real value lies. 5

Why the trend matters more than one number
CEA (ng/mL)Nonsmoker cutoff ~3DiagnosisSurgery6 wks3 mo6 mo12 mo18 mo24 moTumor removed
Illustrative. The shape is grounded in cited facts: CEA should fall to normal within about 6 weeks of colorectal tumor removal, and a later rise across serial tests is what flags a possible recurrence. The dashed segment shows what a recurrence might look like, not a specific patient.

A tumor marker clears the blood at its own pace, so its level drifts down after successful treatment instead of dropping all at once. That is why the trend across tests, not a lone reading, carries the meaning.

LifeFrom, Tumor markers explained

For the bigger picture on why these numbers behave this way, see tumor markers explained.

Why CEA is not a screening test

CEA cannot find cancer in a healthy person, for two reasons that pull in opposite directions. First, plenty of things that are not cancer push it up. Second, plenty of colorectal cancers, especially early ones, never raise it at all, so a normal CEA is not a clean bill of health. Michael Duffy's review in Clinical Chemistry put it plainly: CEA is "of little use in detecting early colorectal cancer." 5

CategoryCommon reasons CEA risesHow it changes the number
LifestyleSmokingRaises CEA on its own; smokers get a higher normal cutoff (usually under 5.0 ng/mL versus about 3.0 ng/mL)
Benign conditionsInflammatory bowel disease (Crohn's, ulcerative colitis), pancreatitis, cirrhosis and other liver disease, COPD (a chronic lung disease) and other lung problems, peptic ulcersMild to moderate rises with no cancer present
Cancer-related (in someone already diagnosed)Colorectal cancer most often; also pancreatic, stomach, lung, breast, ovarian, and medullary thyroid cancersCEA cannot say which organ; it is read next to a known diagnosis and imaging

Smoking is the single most common benign reason CEA is up, which is why labs apply a higher cutoff for smokers. 34 Because CEA rises across several cancers and many benign conditions, a raised number can never name its own source. 3

What is a normal CEA level?

Reference ranges are lab-dependent, and CEA values are method-dependent, so the same testing method should be used each time you are monitored. A common pattern looks like this. 4

GroupUsual reference cutoffNotes
Nonsmoker3.0 ng/mL or lessAbout 97% of healthy nonsmokers fall here 4
SmokerUnder 5.0 ng/mLSmoking raises baseline CEA on its own
Above 20 ng/mLFlagged for the care teamLabs flag grossly high values for prompt review by the care team; only a full workup can interpret them, and the number alone confirms nothing

Where an example CEA falls (nonsmoker cutoffs)ng/mL

2.4 ng/mLwithin the usual nonsmoker range · a smoker's lab might not flag a value until 5.0
Usual nonsmoker range0–3Reads two ways (lab- and smoker-dependent)3–5Above the smoker cutoff5–10
An example reading of 2.4 ng/mL sits inside the usual nonsmoker range. A single value means little by itself; for someone being followed after cancer treatment, the trend across repeat tests is what the care team watches. Bring any result to the clinician who ordered it.
Illustrative example. Cutoffs from Mayo Clinic Laboratories: about 3.0 ng/mL for nonsmokers, under 5.0 ng/mL for smokers, and lab-dependent. [[4]]

What does a high CEA mean?

A high CEA means the number is worth explaining, not that you have cancer. In someone with no cancer diagnosis, the usual explanations are smoking or a benign condition, and the next step is a conversation with the ordering clinician. In someone being monitored after a cancer diagnosis, a single high reading still is not proof of anything; the oncology team looks at whether it is rising across successive tests and what the scans show. Mayo Clinic Laboratories is blunt about what the number can and cannot prove about cancer, also called malignant disease:

Do not interpret serum CEA levels as absolute evidence of the presence or the absence of malignant disease.Mayo Clinic Laboratories, Carcinoembryonic Antigen (CEA), Serum

What cancer does CEA detect?

None, on its own. CEA does not detect cancer; it tracks one that has already been found. It is used most in colorectal cancer, and it can also rise in pancreatic, stomach, lung, breast, ovarian, and medullary thyroid cancers, 34 but a raised CEA cannot point to which of these, or tell you that any cancer is present at all. That is the difference between a marker and a diagnosis.

How the test is done

CEA is a standard blood draw from a vein, usually ordered on its own rather than bundled into a routine panel, and no fasting is needed. If you are being monitored, the lab should use the same assay (testing method) each time, because values from different assays are not directly comparable. 4 For people treated for colorectal cancer, the endorsed cadence is every 3 to 6 months for up to 5 years, decided by your care team. 2

LifeFrom membershipGet every marker on your panel explained in plain language and read next to the rest of your numbers. Start with a full LifeFrom panel.Get started
Citations
  1. National Cancer Institute, Tumor Markers in Common Use (2024)
  2. Meyerhardt JA et al., Follow-Up Care, Surveillance Protocol, and Secondary Prevention for Survivors of Colorectal Cancer: ASCO Clinical Practice Guideline Endorsement, J Clin Oncol 2013;31(35):4465-4470
  3. Locker GY et al., ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer, J Clin Oncol 2006;24(33):5313-5327
  4. Mayo Clinic Laboratories, Carcinoembryonic Antigen (CEA), Serum (test 8521), test overview
  5. Duffy MJ, Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful? Clinical Chemistry 2001;47(4):624-630

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.